Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) CEO Christopher Bilotto bought 20,000 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were acquired at an average price of $4.89 per share, for a total transaction of $97,800.00. Following the transaction, the chief executive officer owned 266,285 shares in the company, valued at approximately $1,302,133.65. This represents a 8.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Diversified Healthcare Trust Stock Up 1.8%
Shares of DHC opened at $5.06 on Friday. The company has a current ratio of 16.89, a quick ratio of 16.89 and a debt-to-equity ratio of 1.61. Diversified Healthcare Trust has a 12 month low of $2.00 and a 12 month high of $5.09. The firm’s 50 day moving average is $4.52 and its 200-day moving average is $4.03. The stock has a market capitalization of $1.23 billion, a PE ratio of -3.47 and a beta of 2.39.
Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) last issued its quarterly earnings results on Monday, June 2nd. The real estate investment trust reported $0.01 earnings per share (EPS) for the quarter. Diversified Healthcare Trust had a negative return on equity of 18.90% and a negative net margin of 22.90%.The business had revenue of $370.78 million for the quarter.
Diversified Healthcare Trust Dividend Announcement
Wall Street Analysts Forecast Growth
A number of research firms recently commented on DHC. B. Riley reaffirmed a “buy” rating and issued a $6.50 price target (up previously from $5.50) on shares of Diversified Healthcare Trust in a research note on Monday. Weiss Ratings restated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada raised shares of Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and upped their price target for the stock from $3.00 to $5.00 in a report on Thursday, November 13th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $5.75.
Get Our Latest Research Report on Diversified Healthcare Trust
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the business. Deutsche Bank AG boosted its stake in shares of Diversified Healthcare Trust by 11.7% in the 1st quarter. Deutsche Bank AG now owns 233,202 shares of the real estate investment trust’s stock valued at $560,000 after purchasing an additional 24,510 shares in the last quarter. Nuveen LLC bought a new position in Diversified Healthcare Trust in the 1st quarter valued at approximately $1,673,000. Resona Asset Management Co. Ltd. lifted its stake in Diversified Healthcare Trust by 12.6% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 94,531 shares of the real estate investment trust’s stock valued at $233,000 after purchasing an additional 10,562 shares during the last quarter. American Century Companies Inc. acquired a new stake in Diversified Healthcare Trust in the first quarter valued at approximately $202,000. Finally, Algert Global LLC grew its stake in shares of Diversified Healthcare Trust by 11.3% during the first quarter. Algert Global LLC now owns 390,767 shares of the real estate investment trust’s stock worth $938,000 after buying an additional 39,670 shares during the last quarter. Institutional investors and hedge funds own 75.98% of the company’s stock.
About Diversified Healthcare Trust
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.
See Also
- Five stocks we like better than Diversified Healthcare Trust
- Investing in Commodities: What Are They? How to Invest in Them
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- Business Services Stocks Investing
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
